Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

The skeletal consequences of thyrotoxicosis.

Nicholls JJ, Brassill MJ, Williams GR, Bassett JH.

J Endocrinol. 2012 Jun;213(3):209-21. doi: 10.1530/JOE-12-0059. Review.

2.

[Thyroid hormone and bone mass].

Nóvoa Mogollón FJ.

Med Clin (Barc). 1994 Nov 26;103(18):695-6. Review. Spanish. No abstract available.

PMID:
7808076
3.

Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women.

Murphy E, Glüer CC, Reid DM, Felsenberg D, Roux C, Eastell R, Williams GR.

J Clin Endocrinol Metab. 2010 Jul;95(7):3173-81. doi: 10.1210/jc.2009-2630.

PMID:
20410228
4.

The effect of long-term thyroxine on bone mineral density and serum cholesterol.

Fowler PB, McIvor J, Sykes L, Macrae KD.

J R Coll Physicians Lond. 1996 Nov-Dec;30(6):527-32.

PMID:
8961207
5.

[Osteoporosis treatment in patients with hyperthyroidism].

Saito J, Nishikawa T.

Nihon Rinsho. 2009 May;67(5):1011-6. Review. Japanese.

PMID:
19432125
6.

Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.

Ongphiphadhanakul B, Puavilai G, Rajatanavin R.

J Med Assoc Thai. 1996 Sep;79(9):563-7.

PMID:
8996984
7.

Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.

Guo CY, Weetman AP, Eastell R.

Clin Endocrinol (Oxf). 1997 Mar;46(3):301-7.

PMID:
9156039
8.

Subclinical thyroid dysfunction.

Woeber KA.

Arch Intern Med. 1997 May 26;157(10):1065-8. Review.

PMID:
9164371
9.

[Thyroid and osteoporosis].

Földes J, Lakatos P.

Orv Hetil. 1996 Jun 23;137(25):1347-54. Review. Hungarian.

PMID:
8757081
10.

A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only.

Papi G, Pearce EN, Braverman LE, Betterle C, Roti E.

Am J Med. 2005 Apr;118(4):349-61. Review. Erratum in: Am J Med. 2005 Aug;118(8):933. Papi, Giovanni [corrected to Papi, Giampaolo].

PMID:
15808130
11.

[Effects of thyroid disorders on the bone].

Mikosch P.

Wien Med Wochenschr. 2005 Oct;155(19-20):444-53. Review. German.

PMID:
16425000
12.

Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy.

Nuzzo V, Lupoli G, Esposito Del Puente A, Rampone E, Carpinelli A, Del Puente AE, Oriente P.

Gynecol Endocrinol. 1998 Oct;12(5):333-7.

PMID:
9859026
13.

Effect of replacement doses of thyroxine on bone mineral density.

Hanna FW, Pettit RJ, Ammari F, Evans WD, Sandeman D, Lazarus JH.

Clin Endocrinol (Oxf). 1998 Feb;48(2):229-34.

PMID:
9579237
14.

Hyperthyroidism, thyroid hormone therapy, and bone.

Ross DS.

Thyroid. 1994 Fall;4(3):319-26. Review.

PMID:
7833670
15.

Bone mineral density in thyroxine treated females with or without a previous history of thyrotoxicosis.

Franklyn J, Betteridge J, Holder R, Daykin J, Lilley J, Sheppard M.

Clin Endocrinol (Oxf). 1994 Oct;41(4):425-32.

PMID:
7955453
16.

Thyroid-stimulating hormone, thyroid hormones, and bone loss.

Zaidi M, Davies TF, Zallone A, Blair HC, Iqbal J, Moonga SS, Mechanick J, Sun L.

Curr Osteoporos Rep. 2009 Jul;7(2):47-52.

PMID:
19631028
17.

Actions of thyroid hormones in bone.

Williams GR.

Endokrynol Pol. 2009 Sep-Oct;60(5):380-8. Review.

PMID:
19885809
18.

Thyroid hormones: beneficial or deleterious for bone?

Lakatos P.

Calcif Tissue Int. 2003 Sep;73(3):205-9. Review.

PMID:
14667131
19.

[Autonomy of the thyroid gland: is there an "organ hyperthyroidism" of "euthyroid" patients?].

Wawrzyn H, Hesch RD.

Med Klin (Munich). 2000 Aug 15;95(8):421-8. German.

PMID:
10985062
20.

Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.

Bagger YZ, Tankó LB, Alexandersen P, Hansen HB, Møllgaard A, Ravn P, Qvist P, Kanis JA, Christiansen C.

Bone. 2004 Apr;34(4):728-35.

PMID:
15050905
Items per page

Supplemental Content

Support Center